{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,21]],"date-time":"2026-02-21T07:01:45Z","timestamp":1771657305114,"version":"3.50.1"},"reference-count":23,"publisher":"Wiley","issue":"10","license":[{"start":{"date-parts":[[2009,9,17]],"date-time":"2009-09-17T00:00:00Z","timestamp":1253145600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Int J Dermatology"],"published-print":{"date-parts":[[2009,10]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p><jats:bold>Background\u2002<\/jats:bold> Dermatitis cruris pustulosa et atrophicans (DCPA) is a distinctive type of chronic superficial folliculitis, with a number of unique features such as its peculiar symmetric localization to legs, extreme chronicity, resistance to therapy, and inevitable alopecia and atrophy.<\/jats:p><jats:p><jats:bold>Methods\u2002<\/jats:bold> All patients with DCPA, attending the Dermatology Outpatient Department at Jawaharlal Institute of Postgraduate Medical Education and Research (JIPMER) Hospital, Pondicherry, from December 2006 to June 2008 were included. Parameters recorded were detailed history and examination, hemogram, erythrocyte sedimentation rate, random blood sugar, skin biopsy and cultures from pus and carrier sites (nares, axillae and gluteal fold).<\/jats:p><jats:p><jats:bold>Results\u2002<\/jats:bold> 37 patients were studied (35 males and 2 females). Sixteen patients (43.24%) belonged to the 21\u201330 year\u2010old age group. The disease most commonly began on the legs (81.1%). Majority (78.38%) had a disease duration of less than 5 years. Itching was the most common symptom (89.19%), followed by bleeding and scaling, with no significant systemic symptoms. The lower limbs were involved in all patients. Eleven patients (29.73%) had involvement of other sites \u2013 beard, axillae, chest, moustache, abdomen, and eyebrows. Pustules, papules, and scaling were seen in all patients, followed by wiry roughness, atrophy, alopecia, and pigmentation. Aggravating factors included use of full\u2010length synthetic trousers, occupational exposure to potential irritants, and season (summer). Pus culture from the folliculitic lesions grew <jats:italic>Staphylococcus aureus<\/jats:italic> in 32 (86.49%) patients. Twenty one patients (56.75%) were carriers of <jats:italic>S. aureus<\/jats:italic> in one or more sites.<\/jats:p><jats:p><jats:bold>Conclusion\u2002<\/jats:bold> DCPA is a chronic folliculitis of the legs, with a multifactorial etiopathogenesis, in which staphylococcal carrier status may be a new potential pathogenetic factor.<\/jats:p>","DOI":"10.1111\/j.1365-4632.2009.04156.x","type":"journal-article","created":{"date-parts":[[2009,9,17]],"date-time":"2009-09-17T10:21:51Z","timestamp":1253182911000},"page":"1082-1090","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Dermatitis cruris pustulosa et atrophicans revisited: our experience with 37 patients in south India"],"prefix":"10.1111","volume":"48","author":[{"given":"Sowmya","family":"Kaimal","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mariette","family":"D'Souza","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rashmi","family":"Kumari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Subhash Chandra","family":"Parija","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sujatha","family":"Sistla","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bhawana Ashok","family":"Badhe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2009,9,17]]},"reference":[{"key":"e_1_2_6_2_2","first-page":"35","article-title":"Folliculitis cruris pustulosa et atrophicans","volume":"39","author":"Sugathan P","year":"1973","journal-title":"Indian J Dermatol Venereol Leprol"},{"key":"e_1_2_6_3_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.1968.tb12268.x"},{"key":"e_1_2_6_4_2","first-page":"116","article-title":"Dermatitis cruris pustulosa et atrophicans","volume":"53","author":"Tiwari V","year":"1987","journal-title":"Indian J Dermatol Venereol Leprol"},{"key":"e_1_2_6_5_2","first-page":"237","article-title":"Clinical, bacteriological and immunological profile of 20 patients with dermatitis cruris pustulosa et atrophicans","volume":"55","author":"Parikh D","year":"1989","journal-title":"Indian J Dermatol Venereol Leprol"},{"key":"e_1_2_6_6_2","first-page":"304","article-title":"Chronic folliculitis \u2013 a clinico\u2010epidemiological study","volume":"63","author":"Prasad PVS","year":"1997","journal-title":"Indian J Dermatol Venereol Leprol"},{"key":"e_1_2_6_7_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1529-8019.2008.00204.x"},{"key":"e_1_2_6_8_2","first-page":"89","article-title":"Therapy resistant folliculitis on legs in adult males with hypergammaglobulinemia","volume":"30","author":"Desai SC","year":"1964","journal-title":"Indian J Dermatol Venereol Leprol"},{"key":"e_1_2_6_9_2","first-page":"79","article-title":"Chronic folliculitis in Sri Lanka","volume":"62","author":"Kumarasinghe SPW","year":"1996","journal-title":"Indian J Dermatol Venereol Leprol"},{"key":"e_1_2_6_10_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.1966.tb12213.x"},{"key":"e_1_2_6_11_2","first-page":"71","article-title":"Septrin in the treatment of dermatitis cruris pustulosa et atrophicans","volume":"95","author":"Jacyk WK","year":"1976","journal-title":"Br J Dermatol"},{"key":"e_1_2_6_12_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-4632.2007.03218.x"},{"key":"e_1_2_6_13_2","first-page":"223","article-title":"Efficacy of cotrimoxazole and PUVA for the management of chronic folliculitis of legs","volume":"56","author":"Shenoy K","year":"1990","journal-title":"Indian J Dermatol Venereol Leprol"},{"key":"e_1_2_6_14_2","first-page":"179","article-title":"The efficacy of PUVA therapy in dermatitis cruris pustulosa et atrophicans","volume":"44","author":"Das J","year":"1999","journal-title":"Indian J Dermatol"},{"key":"e_1_2_6_15_2","first-page":"212","article-title":"Ciprofloxacin therapy in chronic folliculitis of legs","volume":"61","author":"Balachandran C","year":"1995","journal-title":"Indian J Dermatol Venereol Leprol"},{"key":"e_1_2_6_16_2","first-page":"9","article-title":"Pentoxifylline and ciprofloxacin in chronic folliculitis of legs","volume":"63","author":"Prasad D","year":"1997","journal-title":"Indian J Dermatol Venereol Leprol"},{"key":"e_1_2_6_17_2","first-page":"16","article-title":"Rifampicin and dapsone in superficial pustular folliculitis","volume":"62","author":"Prasad PVS","year":"1996","journal-title":"Indian J Dermatol Venereol Leprol"},{"key":"e_1_2_6_18_2","first-page":"334","article-title":"Minocycline in chronic folliculitis of legs","volume":"62","author":"Prasad PVS","year":"1996","journal-title":"Indian J Dermatol Venereol Leprol"},{"key":"e_1_2_6_19_2","first-page":"207","article-title":"Mupirocin in folliculitis cruris pustulosa et atrophicans","volume":"64","author":"Kumar B","year":"1998","journal-title":"Indian J Dermatol Venereol Leprol"},{"key":"e_1_2_6_20_2","doi-asserted-by":"publisher","DOI":"10.1001\/archderm.1956.01550080001001"},{"key":"e_1_2_6_21_2","volume-title":"Ananthanarayan and Paniker's Textbook of Microbiology","author":"Ananthanarayan R","year":"2005"},{"key":"e_1_2_6_22_2","first-page":"814","volume-title":"Harrison's Principles of Internal Medicine","author":"Lowy FD","year":"2005"},{"key":"e_1_2_6_23_2","doi-asserted-by":"publisher","DOI":"10.1128\/CMR.10.3.505"},{"key":"e_1_2_6_24_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-4362.1978.tb05984.x"}],"container-title":["International Journal of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-4632.2009.04156.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1365-4632.2009.04156.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,15]],"date-time":"2023-10-15T08:00:50Z","timestamp":1697356850000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1365-4632.2009.04156.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,9,17]]},"references-count":23,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2009,10]]}},"alternative-id":["10.1111\/j.1365-4632.2009.04156.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1365-4632.2009.04156.x","archive":["Portico"],"relation":{},"ISSN":["0011-9059","1365-4632"],"issn-type":[{"value":"0011-9059","type":"print"},{"value":"1365-4632","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,9,17]]},"assertion":[{"value":"2009-09-17","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}